Literature DB >> 6401210

Five leucocyte labelling techniques: a comparative in-vitro study.

N Colas-Linhart, M Barbu, M A Gougerot, B Bok.   

Abstract

During the past years, several authors have used labelled leucocytes to detect inflammatory foci. However, before routine use in man. It is necessary to control the viability of labelled cells. Five leucocyte labelling techniques (111In-oxine, 111In-oxine without extraction, 99mTc oxine, pyrophosphate 99mTc, 51Cr) were compared using the same separation methods, conservation medium, viability assays and migration studies. Electron microscopic studies allowed the assessment of cellular damage induced by the labelling techniques as well as the calculation of the percentage of cells disrupted during preparation. Results obtained in vitro using 111In-oxine were not satisfactory and in fact appeared contradictory to those published by the authors using this technique in vivo. Even the best method, pyrophosphate 99mTc labelling, was not completely atoxic, but the functional behaviour of the leucocytes did not seem affected. While in vitro studies offer much information concerning labelled cells, they cannot predict the in vivo behaviour of these cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401210     DOI: 10.1111/j.1365-2141.1983.tb01983.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Upregulation of granulocyte CD11b (CR 3) after labelling with technetium-99m hexamethylpropylene amine oxime.

Authors:  S Almer; O Ljunghusen
Journal:  Eur J Nucl Med       Date:  1995-09

Review 2.  Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging.

Authors:  Peter J Gawne; Francis Man; Philip J Blower; Rafael T M de Rosales
Journal:  Chem Rev       Date:  2022-05-12       Impact factor: 72.087

3.  99mTc labeling white blood cells with a simple technique: clinical application.

Authors:  B Gutfilen; M P Pellini; J de Roure e Neder; J L de Amarante Júnior; M G Evangelista; S R Fernandes; M Bernardo-Filho
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.